21 results match your criteria: "Parc Sanitari Sant Joan de Deu Hospital[Affiliation]"
Vasc Med
August 2023
Chair for the Study of Thromboembolic Disease, Faculty of Health Sciences, UCAM - Universidad Católica San Antonio de Murcia, Barcelona, Spain.
Background: The natural history of patients with a pacemaker-related upper-extremity deep vein thrombosis (UEDVT) has not been consistently studied.
Methods: We used the RIETE registry data to compare the outcomes during anticoagulation and after its discontinuation in noncancer patients with symptomatic UEDVT associated with a pacemaker, other catheters, or no catheter. The major outcome was the composite of symptomatic pulmonary embolism or recurrent DVT.
Eur Neuropsychopharmacol
May 2023
Parc Sanitari Sant Joan de Deu Hospital, Sant Joan de Deu Research Foundation, Spain.
J Gen Intern Med
June 2023
Faculty of Health Sciences, UCAM - Universidad Católica San Antonio de Murcia, Murcia, Spain.
Background: Chronic immobility is prevalent, especially as people age. However, little is known about venous thromboembolism (VTE) outcomes in this population.
Objective: To compare the presentation, treatment, and outcomes in chronically immobile (>8 weeks) patients older vs.
Thromb Res
May 2022
Department of Internal Medicine, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain; Chair for the Study of Thromboembolic Disease, Faculty of Health Sciences, UCAM - Universidad Católica San Antonio de Murcia, Universidad Autónoma de Barcelona, Spain.
Background: Upper extremity deep vein thrombosis (UEDVT) related to thoracic outlet syndrome (TOS) is rare, and the literature is limited to institutional case series.
Methods: We used data from the RIETE Registry to compare outcomes (recurrences, major bleeding and signs and symptoms of post-thrombotic [PTS] syndrome) in patients with UEDVT and TOS undergoing first rib resection vs. those not undergoing surgery.
Br J Haematol
July 2021
Department of Internal Medicine, Hospital Germans Trias i Pujol, Universidad Autonoma de Barcelona, Barcelona, Spain.
Autoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data on the risk of recurrent VTE in people with autoimmune disease is sparse. We explored the risk of recurrent VTE using the RIETE registry, comparing people with autoimmune disease (n = 1305) to those without (n = 50608).
View Article and Find Full Text PDFHIV Med
February 2021
Ifakara branch, Ifakara Health Institute, Ifakara, Tanzania.
Objectives: Few studies have assessed cognitive impairment among healthy people living with HIV (PLWH) who are stable on antiretroviral treatment (ART) in sub-Saharan Africa.
Methods: We conducted a cross-sectional study among a random sample of stable adult PLWH from rural Tanzania on ART for more than 1 year and without immunological failure or pre-existing neurological disease. We evaluated the prevalence and risk factors for neurocognitive impairment (NCI), assessed through neuropsychological tests, functional and depression questionnaires and defined as a mean Z-score ≤ -1 in two or more cognitive domains.
TH Open
July 2020
Department of Internal Medicine, Hospital Germans Trias i Pujol, Badalona, Barcelona, Universidad Católica de Murcia, Spain.
We previously reported that during the course of anticoagulation for venous thromboembolism (VTE) patients using statins were at a lower risk to die than nonusers. We used the R egistro I nformatizado E nfermedad T rombo E mbólica (RIETE) registry to validate our previous findings in a subsequent cohort of patients and to compare the risk of death according to the use of different types of statins. From January 2018 to December 2019, 19,557 patients with VTE were recruited in RIETE.
View Article and Find Full Text PDFThromb Res
September 2020
Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain; Universidad Autónoma de Barcelona, Barcelona, Spain.
Objective: To address the association between psychiatric disorders and short-term outcomes after acute symptomatic pulmonary embolism (PE).
Methods: We identified adults with PE enrolled in the RIETE registry between December 1, 2013, and January 31, 2019. Using multinomial regression, we assessed the association between a history of psychiatric disorders and the outcomes of all-cause mortality, PE-related mortality, and venous thromboembolism recurrence and bleeding rates through 30 days after initiation of treatment.
Thromb Haemost
April 2020
Department of Internal Medicine, Hospital Germans Trias i Pujol, Universidad Autónoma de Barcelona, Badalona, Barcelona, Spain.
Background: The influence (if any) of the use of psychotropic drugs on outcome in patients receiving anticoagulant therapy for venous thromboembolism (VTE) has not been consistently evaluated.
Methods: We used data from the RIETE (Registro Informatizado Enfermedad TromboEmbólica) database to compare the risk for VTE recurrences, major bleeding, or death during the course of anticoagulant therapy, according to the use of psychotropics at baseline.
Results: Among 49,007 patients with VTE enrolled from February 2009 to September 2019, total 5,230 (11%) were using psychotropics at baseline: antidepressants 3,273 (6.
Int J Cardiol
April 2020
Department of Internal Medicine and Emergency Room, Ospedale Buon Consiglio Fatebenefratelli, Naples, Italy.
Background: Limited data exist about the clinical presentation and outcomes of patients with inferior vena cava agenesis (IVCA) who develop deep vein thrombosis (DVT).
Methods: We used the RIETE (Registro Informatizado Enfermedad Trombo Embólica) registry to compare clinical characteristics and outcomes of patients with lower limb DVT, according to the presence or absence of IVCA. Major outcomes included recurrent DVT, major bleeding and post-thrombotic syndrome (PTS).
Intern Emerg Med
October 2020
Department of Internal Medicine, Hospital Universitari Germans Trias I Pujol, Universidad Autónoma de Barcelona, Carretera del Canyet s.n., Badalona, 08916, Barcelona, Spain.
In the original publication, part of the conflict of statement was incorrectly published as "Dr. Bikdeli reports that he was approached by lawyers on behalf of plaintiffs in litigation related to IVC filters". The correct statement should read as "Dr.
View Article and Find Full Text PDFJ Healthc Qual Res
June 2020
Unidad de Cuidados Intensivos, Parc Sanitari Sant Joan de Déu Hospital General, Sant Boi de Llobregat, Barcelona, España.
Introduction: The emotional experience of patients must be ascertained to ensure patient-centred care during hospitalisation. Improving this experience has a positive impact on patient prognosis. Therefore, in order to provide comprehensive care, therefore, patient emotional care needs must be known.
View Article and Find Full Text PDFJ Intern Med
January 2020
Meir Medical Center, Hematology Institute and Blood Bank, Kfar Saba, Israel.
Background: Patients with venous thromboembolism (VTE) secondary to transient risk factors may develop VTE recurrences after discontinuing anticoagulation. Identifying at-risk patients could help to guide the duration of therapy.
Methods: We used the RIETE database to assess the prognostic value of d-dimer testing after discontinuing anticoagulation to identify patients at increased risk for recurrences.
Intern Emerg Med
October 2019
Department of Internal Medicine, Hospital Universitari Germans Trias I Pujol, Universidad Autónoma de Barcelona, Carretera del Canyet s.n., Badalona, 08916, Barcelona, Spain.
In the original publication, part of conflict of statement was incorrectly published.
View Article and Find Full Text PDFIntern Emerg Med
October 2019
Department of Internal Medicine, Hospital Universitari Germans Trias I Pujol, Universidad Autónoma de Barcelona, Carretera del Canyet s.n., Badalona, 08916, Barcelona, Spain.
The association between inferior vena cava filter (IVC) use and outcome in patients presenting with major bleeding during anticoagulation for venous thromboembolism (VTE) has not been thoroughly investigated. We used the RIETE registry to compare the 30-day outcomes (death, major re-bleeding or VTE recurrences) in VTE patients who bled during the first 3 months of therapy, regarding the insertion of an IVC filter. A propensity score matched (PSM) analysis was performed to adjust for potential confounders.
View Article and Find Full Text PDFThromb Res
January 2019
Department of Internal Medicine, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain. Universidad Católica de Murcia, Spain.
Background And Aims: Sex-specific differences exist for the initial presentation of acute venous thromboembolism (VTE): men are more likely to present with proximal deep vein thrombosis (DVT) in the lower limbs (versus pulmonary embolism [PE] or isolated distal DVT [IDDVT]) than women. We studied in detail the influence of sex, age, and VTE risk factors on the initial presentation of IDDVT versus proximal DVT.
Methods: A total of 24,911 patients with a first episode of objectively diagnosed acute symptomatic lower-limb DVT (without symptomatic PE) were enrolled in RIETE (years 2000-2017) and included in the present analysis.
Thromb Res
March 2017
Department of Internal Medicine, Hospital Universitario Germans Trias i Pujol de Badalona, Barcelona, Universidad Católica de Murcia, Spain.
Background: Women presenting with uterine bleeding during the course of anticoagulant therapy for venous thromboembolism (VTE) present a difficult therapeutic dilemma due to the absence of evidence-based recommendations.
Methods: We used the RIETE (Registro Informatizado Enfermedad TromboEmbólica) database to assess the clinical characteristics of women presenting with uterine bleeding during anticoagulation for VTE, its frequency, time course, management and 30-day outcomes.
Results: As of October 2016, 31,951 women with VTE were recruited in RIETE.
PLoS One
March 2016
Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Current guidelines of antithrombotic therapy suggest early initiation of vitamin K antagonists (VKA) in non-cancer patients with venous thromboembolism (VTE), and long-term therapy with low-molecular weight heparin (LMWH) for those with cancer. We used data from RIETE (international registry of patients with VTE) to report the use of long-term anticoagulant therapy over time and to identify predictors of anticoagulant choice (regarding international guidelines) in patients with- and without cancer. Among 35,280 patients without cancer, 82% received long-term VKA (but 17% started after the first week).
View Article and Find Full Text PDFThromb Res
February 2015
Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. Electronic address:
Background: The outcome of cancer patients with acute venous thromboembolism (VTE) may differ according to gender.
Methods: We used the RIETE database to compare the rate of VTE (pulmonary embolism [PE] or deep vein thrombosis [DVT]) recurrences), major bleeding and mortality during the course of anticoagulation, according to gender.
Results: As of August 2014, 11,055 patients with active cancer were enrolled in RIETE, of whom 5,104 (46%) were women.
Infant Behav Dev
February 2015
Institute for Brain, Cognition and Behaviour (IR3C), Barcelona, Spain; Departament de Psicologia Bàsica, Facultat de Psicologia, Universitat de Barcelona, Barcelona, Spain.
Front Psychol
October 2012
Fundació Sant Joan de Déu, Parc Sanitari Sant Joan de Déu - Hospital Sant Joan de Déu Esplugues de Llobregat, Barcelona, Spain.